Mesothelioma Biopsies: Ultrasound Guidance Beats CT
| | | |

Mesothelioma Biopsies: Ultrasound Guidance Beats CT

A new study concludes that ultrasound guided mesothelioma biopsies are safer and just as effective as CT guided biopsies.  Italian researchers analyzed both types of guidance systems for collecting tissue samples from mesothelioma patients. They compared the diagnostic yield and safety of each method.  It turns out that ionizing radiation is not necessary for successful mesothelioma biopsies. As long as the technician is experienced, ultrasound guidance may be the better choice.  The Importance of Mesothelioma Biopsies Pleural mesothelioma is a rare but highly aggressive kind of cancer. It grows on the membrane that surrounds the lungs. By the time patients experience symptoms of mesothelioma, the disease is often very advanced.  Malignant mesothelioma can be tricky to diagnose. Mesothelioma biopsies are…

P16 Test May Improve Diagnostic Accuracy for Mesothelioma
| | |

P16 Test May Improve Diagnostic Accuracy for Mesothelioma

Scientists in the UK say testing for a tumor suppressor protein called p16 can improve diagnostic accuracy for mesothelioma. It may also help predict which patients are likely to have the best treatment response. The p16 protein is encoded by the CDKN2A gene. Many people with mesothelioma are missing this gene.  Previous studies show a lack of p16 may be linked to lower cancer survival. Now, researchers in Manchester say it should be added to routine tests to improve prognostic and diagnostic accuracy for mesothelioma. The Challenge of Diagnostic Accuracy for Mesothelioma It is not easy to diagnose mesothelioma. There is no single test that can show if a person has this cancer. Diagnosis usually involves blood tests, imaging studies,…

Liquid Biopsy for Early Stage Mesothelioma Diagnosis
| | | |

Liquid Biopsy for Early Stage Mesothelioma Diagnosis

Canadian researchers are exploring a liquid biopsy test that could lead to early diagnosis of malignant mesothelioma. The test is based on mesothelial precursor cells (MPC). The researchers say these cells – in combination with mesothelin and some kinds of stem cells – “could be implicated” in the development of mesothelioma.  A liquid biopsy detects cells in blood instead of tissue. The University of Toronto scientists think MPC in blood may be a new mesothelioma biomarker. If it proves to be true, this kind of biopsy might be able to identify mesothelioma patients even before they have symptoms. How Liquid Biopsy Works Patients with suspected mesothelioma may have many tests. Imaging scans and blood tests can help tell if a…

Recurrent Pleural Effusion Could Signal High Mesothelioma Risk
| | | |

Recurrent Pleural Effusion Could Signal High Mesothelioma Risk

The case of a Japanese woman with recurrent pleural effusion suggests the problem could be a precursor of malignant pleural mesothelioma. Pleural effusion is a build-up of fluid on the space between the layers of the membrane that surrounds the lungs. It is common with mesothelioma and some other cancers.  In the new case study, the patient had recurrent pleural effusion for 15 years before she developed mesothelioma in situ. This is the earliest stage of asbestos cancer, before it becomes invasive. Her doctors say patients with similar problems should be tested for BAP1 loss and other signs of mesothelioma in situ.  Understanding Recurrent Pleural Effusion Pleural effusion is a side effect of several conditions including heart disease and cancer….

The Best Biomarkers for Mesothelioma Diagnosis, Prognosis, & Monitoring
| |

The Best Biomarkers for Mesothelioma Diagnosis, Prognosis, & Monitoring

What are the best biomarkers for mesothelioma? The answer is still Soluble Mesothelin-Related Proteins (SMRPs). That is the conclusion of a major review of medical literature by some of the world’s top mesothelioma experts. Dr. Harvey Pass of New York University’s Langone Medical Center and Dr. Michele Carbone of the University of Hawaii are among the authors on the new report.  They analyzed 20 years of research on the best biomarkers for mesothelioma. Several were valuable for mesothelioma prognosis. But SMRPs once again came out the winner for mesothelioma prognosis, diagnosis, and treatment monitoring.  How Do Biomarkers Work? A biomarker is any substance produced by the body that can act as a biological signpost. Proteins usually make the best biomarkers…

Lung Fluid Analysis Could Enhance Mesothelioma Survival, Report Finds
| | |

Lung Fluid Analysis Could Enhance Mesothelioma Survival, Report Finds

Swedish researchers say more people might survive mesothelioma if doctors paid more attention to lung fluid analysis in making their diagnosis. The only way to definitely diagnose mesothelioma is to examine cells under a microscope. But pathologists at Karolinska University Hospital in Stockholm say tissue biopsy happens too late.  Lung fluid starts to collect much earlier in the disease process. The Swedish team says lung fluid analysis (cytology) could give doctors an earlier indication of mesothelioma. That could lead to earlier diagnosis and better survival. Diagnosing Malignant Mesothelioma There are many signs of malignant mesothelioma. Coughing, chest pain, and shortness of breath are some of the most common. When these symptoms occur in someone who has worked around asbestos, that…

Artificial Intelligence in Mesothelioma Diagnosis, Prognosis, and Treatment Planning
| | |

Artificial Intelligence in Mesothelioma Diagnosis, Prognosis, and Treatment Planning

Two newly-published studies highlight some of the ways that artificial intelligence may help with the diagnosis and treatment of malignant mesothelioma.  The first study focuses on machine learning algorithms for mesothelioma diagnosis. Researchers used data from Turkey, which has a high rate of mesothelioma among families.  A separate study from New York’s Mount Sinai Medical Center demonstrates the role that artificial intelligence can play in planning mesothelioma radiotherapy. Both studies suggest that machine learning may be a valuable tool to help doctors tackle asbestos cancer.  How Does Machine Learning Work? Artificial intelligence refers to intelligence generated by a computer. Like people, computers have to “learn” before they can provide intelligent answers to medical questions.  In both of the new studies,…

Epithelioid Mesothelioma and Lung Cancer: Biomarker Shows Which is Which
| | |

Epithelioid Mesothelioma and Lung Cancer: Biomarker Shows Which is Which

Researchers from Hiroshima University say they have found a nearly foolproof way to tell the difference between epithelioid mesothelioma and lung cancer.  This is critical because the prognosis can be very different between the two. They are also treated differently.  But epithelioid mesothelioma and lung cancer are similar in many ways. They cause many of the same symptoms. Even their cells look similar under the microscope. This can make it hard for doctors to deliver an accurate and timely diagnosis.  If the new findings are right, the biomarker identified by the Hiroshima researchers could be a diagnostic gamechanger.  Lung Adenocarcinoma or Pleural Mesothelioma? At first glance, epithelioid mesothelioma and lung cancer seem to be very different. Mesothelioma makes up about…

Breast Cancer and Mesothelioma: Case Study Illustrates Diagnostic Challenge
| | |

Breast Cancer and Mesothelioma: Case Study Illustrates Diagnostic Challenge

A newly published Croatian case illustrates how challenging it can sometimes be to distinguish between breast cancer and mesothelioma. The case involves a 61-year-old woman with what appeared to be breast cancer. Further study revealed that what the woman actually had was pleural mesothelioma. The mesothelioma had spread to her breast.  Breast cancer and mesothelioma cells look similar under the microscope. But they are very different. The authors of the new report caution doctors against the “pitfall” of mistaking one for the other.  Breast Metastasis is Rare Pleural mesothelioma occurs on the membrane that surrounds the lungs. It is rare for mesothelioma to spread to the breast. The most common place for mesothelioma cells to spread is the lungs.  Women…

Mesothelioma and Lung Cancer: These Biomarkers Can Tell the Difference
| |

Mesothelioma and Lung Cancer: These Biomarkers Can Tell the Difference

Researchers in Canada say when it comes to distinguishing between mesothelioma and lung cancer, some proteins are more valuable than others.  The team has identified an especially important protein biomarker for mesothelioma. A biomarker is a compound in body fluid or tissue that can act as a signpost for disease.  Understanding the value of this particular protein as compared to other biomarkers may improve the testing process for mesothelioma. Pleural mesothelioma and lung cancer share many of the same characteristics. Both affect the lungs and both cause similar symptoms. But they are treated differently.  It is not always easy to tell these two cancers apart, even with high-level diagnostic tools. But the biomarker testing completed in Canada may make it…